Document is current
Any future updates will be listed below
-
Authors
Fleming, Chris
Poznyak, Dmitriy
Powell, Rhea
Erba, Claire
Shin, Eunhae
Wang, Rui
Burkhart, Claire
Ghosh, Arkadipta
Rich, Eugene C. https://orcid.org/0000-0003-4973-8607
-
Funding
Funding for this research was provided by:
U.S. Department of Health and Human Services, Centers for Medicare & Medicaid Services (contracts HHSM-500-2014-00034I/75FCMC19F0005 and HHSM-500-2014-00034I/HHSM-500-T0010.)
- License Information
-
More Information
Article History
Received: 12 June 2023
Accepted: 12 June 2026
First Online: 19 June 2026
Declarations
Ethics approval and consent to participate <b>(IRB approval)</b>: The need for informed consent was waived per the New England Institutional Review Board (IRB), which granted the CPC+ evaluation an IRB exemption on the basis of the federal common rule (Sect. 45 CFR 46.101[b][5]), because the purpose of the study was to evaluate a public benefit program.
Consent for publication: Not applicable.
Authors’ information: Not applicable.
Disclaimer: The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the U.S. Department of Health and Human Services or any of its agencies.
Competing interests: The authors declare no competing interests.
